Stock Rating Upgrade
Of late the Value Trend Rating for Zevra Therapeutics Inc (NASDAQ: ZVRA) rose significantly from C to A reflecting improving fundamentals and high Appreciation Potential.
Recent Price Action
On 3/14/25, Zevra Therapeutics Inc (NASDAQ: ZVRA) stock enjoyed a large increase of 4.7%, closing at $8.31. Moreover, this advance was accompanied by unusually high trading volume at 162% of normal. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 3.2% during the last week.
Current PriceTarget Research Rating
Zevra Therapeutics has a current Value Trend Rating of A (Highest Rating). This VT Rating rose significantly in recent days from C previously. With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing inconsistent signals. Zevra Therapeutics has a neutral Appreciation Score of 59 but a very high Power Rating of 87, producing the Highest Value Trend Rating.
Be the first to comment